European Renal Best Practice Guideline on kidney donor and recipient evaluation and perioperative care

Nephrology Dialysis Transplantation

Volumn 30, Issue 11, 2015, Pages 1790-1797

  Abramowicz, Daniel ^a   Cochat, Pierre ^b,c   Claas, Frans H J ^d   Heemann, Uwe ^e   Pascual, Julio ^f   Dudley, C ^g   Harden, Paul ^h   Hourmant, Marivonne ⁱ   Maggiore, Umberto ^j   Salvadori, Maurizio ^k   Spasovski, Goce ^l   Squifflet, Jean Paul ^m   Steiger, Jürg ⁿ   Torres, Armando ^o,p,q   Viklicky, Ondrej ^r   Zeier, Martin ^s   Vanholder, Raymond ^t   Van Biesen, Wim ^t   Nagler, Evi ^t  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ LYON 1   (France)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^f HOSPITAL DEL MAR   (Spain)

^g SOUTHMEAD HOSPITAL   (United Kingdom)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ NANTES UNIVERSITY HOSPITAL   (France)

^j Universitaria di Parma   (Italy)

^k CAREGGI UNIVERSITY HOSPITAL   (Italy)

^l SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

^m UNIVERSITY OF LIÈGE   (Belgium)

ⁿ UNIVERSITY HOSPITAL BASEL   (Switzerland)

^o UNIVERSIDAD DE LA LAGUNA   (Spain)

^p HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^q Nefrologia IdiPAZ   (Spain)

^r INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^s UNIVERSITY OF HEIDELBERG   (Germany)

^t GHENT UNIVERSITY HOSPITAL   (Belgium)

more..

Author keywords

Donor evaluation; ERBP; Guideline; Kidney transplantation; Perioperative care; Recipient evaluation

Indexed keywords

ANTICOAGULANT AGENT; DOPAMINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN;

AGE DISTRIBUTION; ALCOHOL ABUSE; ANGIOCARDIOGRAPHY; ASSESSMENT OF HUMANS; BLOOD GROUP ABO INCOMPATIBILITY; CANCER SCREENING; CARDIOVASCULAR DISEASE; CATHETER REMOVAL; CD4 LYMPHOCYTE COUNT; CENTRAL VENOUS PRESSURE; CHEMOPROPHYLAXIS; CLINICAL EVALUATION; CLINICAL PRACTICE; DECEASED DONOR; DONOR; DONOR SELECTION; DOUBLE J STENT; DRUG ABUSE; DRUG USE; ELECTROCARDIOGRAM; END STAGE RENAL DISEASE; EUROPE; EVIDENCE BASED PRACTICE; EXERCISE TEST; FOCAL GLOMERULOSCLEROSIS; GRADES OF RECOMMENDATION ASSESSMENT DEVELOPMENT AND EVALUATION; GRAFT RECIPIENT; GRAFT SURVIVAL; GRAFT THROMBOSIS; HEALTH CARE QUALITY; HEMATURIA; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HLA MATCHING; HLA TYPING; HUMAN; HYPERTENSION; IMMUNIZATION; INDWELLING CATHETER; KIDNEY DONOR; LIVER CELL CARCINOMA; LIVING DONOR; MACHINE PERFUSION; MEDICAL HISTORY; NEPHRECTOMY; OBESITY; PATIENT SURVIVAL; PERFUSION; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROBABILITY; PROTEINURIA; REVIEW; RISK BENEFIT ANALYSIS; SECONDARY HYPERPARATHYROIDISM; SMOKING; STANDARD PERFUSION; SURGICAL APPROACH; SURVIVAL; THERAPY DELAY; THROMBOSIS; TOTAL QUALITY MANAGEMENT; TREATMENT INDICATION; TREATMENT OUTCOME; UROGENITAL TRACT TUMOR; VARICELLA ZOSTER VIRUS; WAIT LISTING; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; STANDARDS;

EUROPE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; PERIOPERATIVE CARE; TISSUE DONORS; TRANSPLANT RECIPIENTS;

EID: 84948431908     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu216     Document Type: Review

References (0)